We are live on ! Find out more
CIC

Cornercap Investment Counsel Portfolio holdings

AUM $203M
1-Year Est. Return 17.67%
This Fund
S&P 500
This Quarter Est. Return
+0.77%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$568M
AUM Growth
-$9.41M
Cap. Flow
+$1.58M
Cap. Flow %
0.28%
Top 10 Hldgs %
8.56%
Holding
680
New
121
Increased
206
Reduced
110
Closed
119

Top Buys

Rank Stock Value
1
RF icon
Regions Financial
RF
+$2.35M
2
EPAM icon
EPAM Systems
EPAM
+$2.11M
3
MET icon
MetLife
MET
+$2.08M
4
GPN icon
Global Payments
GPN
+$2.03M
5
CZR icon
Caesars Entertainment
CZR
+$2.02M

Top Sells

Rank Stock Value
1
FANG icon
Diamondback Energy
FANG
+$3.57M
2
KEY icon
KeyCorp
KEY
+$2.81M
3
TFC icon
Truist Financial
TFC
+$2.6M
4
TRV icon
Travelers Companies
TRV
+$2.57M
5
CTSH icon
Cognizant
CTSH
+$2.02M

Sector Composition

Rank Sector Weight
1 Financials 19.54%
2 Technology 15.74%
3 Healthcare 14.42%
4 Industrials 12.89%
5 Energy 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COST icon
476
Costco
COST
$419B
$258K 0.05%
520
SBUX icon
477
Starbucks
SBUX
$122B
$257K 0.05%
2,471
MCB icon
478
Metropolitan Bank Holding Corp
MCB
$1.15B
$256K 0.05%
7,557
KHC icon
479
Kraft Heinz
KHC
$29.2B
$252K 0.04%
6,516
-42,657
-87% -$1.69M
TPB icon
480
Turning Point Brands
TPB
$1.77B
$244K 0.04%
11,634
+179
+2% +$3.94K
APH icon
481
Amphenol
APH
$206B
$243K 0.04%
5,940
YMAB
482
DELISTED
Y-mAbs Therapeutics
YMAB
$242K 0.04%
48,233
VIR icon
483
Vir Biotechnology
VIR
$1.51B
$241K 0.04%
10,378
FATE icon
484
Fate Therapeutics
FATE
$319M
$239K 0.04%
+41,863
New +$253K
TTEK icon
485
Tetra Tech
TTEK
$9.06B
$233K 0.04%
7,935
ENTA icon
486
Enanta Pharmaceuticals
ENTA
$393M
$232K 0.04%
5,742
IOVA icon
487
Iovance Biotherapeutics
IOVA
$2.94B
$230K 0.04%
37,683
NTLA icon
488
Intellia Therapeutics
NTLA
$1.68B
$229K 0.04%
+6,156
New +$241K
RCUS icon
489
Arcus Biosciences
RCUS
$3.66B
$226K 0.04%
+12,379
New +$237K
OMER icon
490
Omeros
OMER
$984M
$225K 0.04%
48,472
+636
+1% +$2.3K
FANG icon
491
Diamondback Energy
FANG
$56.5B
$224K 0.04%
1,657
-25,610
-94% -$3.57M
GLUE icon
492
Monte Rosa Therapeutics
GLUE
$1.34B
$220K 0.04%
28,192
HOLX
493
DELISTED
Hologic
HOLX
$219K 0.04%
2,712
-330
-11% -$26.6K
GRTS
494
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$214K 0.04%
77,046
LYEL icon
495
Lyell Immunopharma
LYEL
$365M
$213K 0.04%
+4,509
New +$241K
EWTX icon
496
Edgewise Therapeutics
EWTX
$4.81B
$213K 0.04%
+31,904
New +$296K
APD icon
497
Air Products & Chemicals
APD
$68.9B
$213K 0.04%
740
DLTR icon
498
Dollar Tree
DLTR
$24.6B
$210K 0.04%
1,464
-473
-24% -$68.6K
SAGE
499
DELISTED
Sage Therapeutics
SAGE
$209K 0.04%
+4,984
New +$214K
CRBU icon
500
Caribou Biosciences
CRBU
$168M
$208K 0.04%
39,230
+1,605
+4% +$10K

Similar funds

Cornercap Investment Counsel's Q1 2023 Portfolio in Review

As of Q1 2023, Cornercap Investment Counsel held 680 positions worth $568M, down 1.6% from $578M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.

Cornercap Investment Counsel's Q1 2023 filing shows 121 new, 206 increased, 110 reduced and 119 closed positions. Its largest new stake was Regions Financial: 108,036 shares worth $2.01M. The largest sale was Diamondback Energy, an estimated $3.57M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Cornercap Investment Counsel's largest Q1 2023 buy was Regions Financial: 108,036 shares worth $2.01M.
  • Cornercap Investment Counsel added most to Cigna in Q1 2023, an estimated $1.93M increase.
  • Cornercap Investment Counsel's biggest Q1 2023 reduction was Diamondback Energy, cutting an estimated $3.57M.
  • Cornercap Investment Counsel fully exited KeyCorp in Q1 2023, selling an estimated $2.81M.
  • Cornercap Investment Counsel's ten largest holdings make up 8.6% of its $568M portfolio in Q1 2023.
  • Cornercap Investment Counsel opened 121 new positions and closed 119 in Q1 2023.
  • Cornercap Investment Counsel's portfolio value fell 1.6% quarter-over-quarter to $568M.

Based on Cornercap Investment Counsel's 13F filing for Q1 2023, filed 11 May 2023.